Genocea Biosciences reported $18.03M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agenus AGEN:US $ 159.72M 3.34M
Baxter International BAX:US $ 3916M 26M
Bluebird Bio BLUE:US $ 148.86M 5.97M
Cytokinetics CYTK:US $ 66.84M 0M
Cytori Therapeutics CYTX:US $ 6.97M 2.05M
Genocea Biosciences GNCA:US $ 18.03M 0.65M
Glaxosmithkline GSK:US $ 37835M 13557M
Infinity Pharmaceuticals INFI:US $ 14.34M 0.94M
Mirati Therapeutics MRTX:US $ 119.15M 4.42M
Moderna Inc MRNA:US 6.81B 2.43B
Novavax NVAX:US $ 2156.24M 104.77M
Prothena PRTA:US 40.11M 3.61M